Scientists look to crowd-funding and Big Data to fight superbugs

November 14, 2013
Scientists look to crowd-funding and Big Data to fight superbugs
Most common in hospital settings, there has been a worrying increase in the number of superbug infections in healthy people with no previous hospital exposure. Now scientists want to use 'Big Data' in their quest to tackle infections such as MRSA.

Researchers from the University of Bath and Emory University (USA) are hoping that online crowd-funding can help in efforts to develop a new way to identify and treat toxic superbugs, such as MRSA.

Superbugs pose a major problem for around the world. According to the World Health Organisation in 2011 6.7 million people died from , making them the second biggest killer behind , at 7 million.

Scientists at Bath and Emory want to use the latest sequencing technologies to build a much clearer picture of how these bacteria cause disease. By using 'Big Data' they plan to create an online database that would enable doctors to make quicker and better decisions about treating such infections.

The infections are caused by micro-organisms that have developed resistance to a range of antibiotics making them incredibly difficult to treat. They are most common in hospital settings, affecting severely ill people. However, there has been a worrying increase in the number of cases of infections among healthy people with no previous hospital exposure.

Meticillin-resistant staphylococcus aureus (MRSA) causes a range of problems, from abscesses on the skin, to much more significant problems, especially when it gets into deeper tissue. In the lungs, MRSA can cause pneumonia which in itself can be deadly.

This video is not supported by your browser at this time.

Once in the blood stream, MRSA mortality rates rise up to 40% when the disease can also attack heart tissue causing endocarditis. Recent reports in the USA suggested that infections caused by MRSA caused more deaths than HIV/AIDS.

Current treatments generally involve the prescription of a cocktail of antibiotics, some of which kill the bacteria and others shut off their release of toxins. This approach has led many, including the UK's Chief Medical Officer this March, to highlight concerns about the 'ticking time bomb' of antibiotic resistance.

Explore further: Drug-resistant MRSA bacteria: Here to stay in both hospital, community

Related Stories

Pediatric musculoskeletal MRSA infections on the rise

October 26, 2013

Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus (MRSA) today than ...

MRSA declines are sustained in veterans hospitals nationwide

October 29, 2013

Five years after implementing a national initiative to reduce methicillin-resistant Staphylococcus aureus (MRSA) rates in Veterans Affairs (VA) medical centers, MRSA cases have continued to decline, according to a study in ...

Researchers discover new treatment to cure MRSA infection

November 13, 2013

Recent work from University Distinguished Professor of Biology Kim Lewis promises to overcome one of the leading public health threats of our time. In a groundbreaking study published Wednesday in the journal Nature, Lewis' ...

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.